Tokyo, Oct. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059028) titled 'A Cohort Study on the Association Between Serum Erythropoietin Dynamics and Prognosis in Patients with Metastatic Renal Cell Carcinoma Treated with Belzutifan' on Oct. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Kobe University Graduate School of Medicine
Condition:
Condition - renal cell carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the association between serum erythropoietin (EPO) dynamics during belzutifan therapy and treatment outcomes (progression-free survival) as well as adverse events (anemia and hypoxia) in p...